Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006)
Clinical trial NCT03295266 · TERMINATED
Trial details
- NCT number
- NCT03295266
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2018-03-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.